August 29, 2017 / 5:47 AM / 4 months ago

BRIEF-DBV Technologies completes enrollment in Phase III extension study of Viaskin Peanut

Aug 29 (Reuters) - DBV TECHNOLOGIES SA:

* REG-DBV TECHNOLOGIES ANNOUNCES COMPLETION OF ENROLLMENT IN PHASE III EXTENSION STUDY OF VIASKIN PEANUT

* COMPANY ANTICIPATES TOPLINE DATA FOR PEPITES IN OCTOBER 2017 BASED ON LAST PATIENT VISIT IN AUGUST 2017

* HAS ENROLLED 300 PATIENTS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below